Merck (NYSE: MRK) reported its third quarter 2024 earnings results today.
Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth was 7%.

GAAP net income decreased 33% to $3.15 billion, or $1.24 per share, compared to last year. Adjusted EPS fell 26% to $1.57.
For the full year of 2024, the company expects sales of $63.6-64.1 billion and adjusted EPS of $7.72-7.77.
Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
PNC Financial reports higher Q1 2025 revenue and profit
The PNC Financial Services Group, Inc. (NYSE: PNC) reported higher revenues for the first quarter of 2025 when the financial services company's earnings increased by double digits. Net income attributable
Earnings: Citigroup (C) Q1 profit rises on higher revenues, beats estimates
Citigroup Inc. (NYSE: C) Tuesday reported stronger-than-expected revenue and earnings for the first quarter of 2025. Both revenues and net income increased year-over-year. In the March quarter, net profit was
Bank of America (BAC) Q1 2025 Earnings: Key financials and quarterly highlights
Bank of America (NYSE: BAC) reported its first quarter 2025 earnings results today. Revenue, net of interest expense, was $27.4 billion, up 6% year-over-year, driven by non-interest income growth across